Collegium Pharmaceutical (COLL) Gross Profit (2016 - 2025)
Historic Gross Profit for Collegium Pharmaceutical (COLL) over the last 10 years, with Q3 2025 value amounting to $129.2 million.
- Collegium Pharmaceutical's Gross Profit rose 3344.94% to $129.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $433.2 million, marking a year-over-year increase of 1591.74%. This contributed to the annual value of $377.3 million for FY2024, which is 1568.97% up from last year.
- Collegium Pharmaceutical's Gross Profit amounted to $129.2 million in Q3 2025, which was up 3344.94% from $108.4 million recorded in Q2 2025.
- In the past 5 years, Collegium Pharmaceutical's Gross Profit ranged from a high of $129.2 million in Q3 2025 and a low of -$1.3 million during Q4 2021
- Moreover, its 5-year median value for Gross Profit was $77.4 million (2023), whereas its average is $73.6 million.
- As far as peak fluctuations go, Collegium Pharmaceutical's Gross Profit tumbled by 10300.96% in 2021, and later soared by 383510.88% in 2022.
- Collegium Pharmaceutical's Gross Profit (Quarter) stood at -$1.3 million in 2021, then surged by 3835.11% to $49.8 million in 2022, then surged by 90.06% to $94.6 million in 2023, then increased by 3.87% to $98.3 million in 2024, then soared by 31.42% to $129.2 million in 2025.
- Its Gross Profit was $129.2 million in Q3 2025, compared to $108.4 million in Q2 2025 and $97.3 million in Q1 2025.